HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 7,900 shares of HealthEquity stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $51.11, for a total value of $403,769.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Frank Medici also recently made the following trade(s):
- On Friday, November 3rd, Frank Medici sold 32,404 shares of HealthEquity stock. The stock was sold at an average price of $51.09, for a total value of $1,655,520.36.
- On Monday, November 6th, Frank Medici sold 419,504 shares of HealthEquity stock. The stock was sold at an average price of $52.97, for a total value of $22,221,126.88.
- On Monday, October 9th, Frank Medici sold 316,644 shares of HealthEquity stock. The shares were sold at an average price of $51.96, for a total value of $16,452,822.24.
Shares of HealthEquity, Inc. (HQY) traded down $1.03 during mid-day trading on Friday, hitting $49.74. 308,800 shares of the stock were exchanged, compared to its average volume of 538,053. The company has a market cap of $3,071.01, a PE ratio of 80.59, a price-to-earnings-growth ratio of 2.23 and a beta of 1.77. HealthEquity, Inc. has a 12 month low of $37.62 and a 12 month high of $55.31.
HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.14 by $0.13. The company had revenue of $56.90 million for the quarter, compared to analysts’ expectations of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. HealthEquity’s quarterly revenue was up 28.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.16 EPS. research analysts predict that HealthEquity, Inc. will post 0.7 EPS for the current fiscal year.
WARNING: “HealthEquity, Inc. (HQY) Director Frank Medici Sells 7,900 Shares” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/11/healthequity-inc-hqy-director-frank-medici-sells-7900-shares.html.
Several research analysts recently weighed in on HQY shares. Zacks Investment Research upgraded shares of HealthEquity from a “hold” rating to a “buy” rating and set a $58.00 price objective for the company in a research report on Wednesday, October 11th. BidaskClub upgraded shares of HealthEquity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. TheStreet upgraded shares of HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Cantor Fitzgerald reiterated a “buy” rating and set a $56.00 target price on shares of HealthEquity in a research report on Tuesday, August 29th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of HealthEquity in a research note on Thursday, September 21st. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. HealthEquity has a consensus rating of “Buy” and an average target price of $57.50.
A number of institutional investors have recently added to or reduced their stakes in the business. Wells Fargo & Company MN raised its holdings in HealthEquity by 49.5% in the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock valued at $56,063,000 after acquiring an additional 366,925 shares during the period. Picton Mahoney Asset Management raised its holdings in HealthEquity by 1.7% in the 3rd quarter. Picton Mahoney Asset Management now owns 290,000 shares of the company’s stock valued at $14,667,000 after acquiring an additional 4,800 shares during the period. JPMorgan Chase & Co. raised its holdings in HealthEquity by 3.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 992,819 shares of the company’s stock valued at $49,422,000 after acquiring an additional 31,147 shares during the period. Legal & General Group Plc raised its holdings in HealthEquity by 15.2% in the 3rd quarter. Legal & General Group Plc now owns 100,891 shares of the company’s stock valued at $5,100,000 after acquiring an additional 13,350 shares during the period. Finally, Eagle Asset Management Inc. bought a new position in HealthEquity in the 3rd quarter valued at about $36,875,000. 91.40% of the stock is currently owned by hedge funds and other institutional investors.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.